Defective Mismatch Repair and Benefit from Bevacizumab for Colon Cancer: Findings from NSABP C-08.

Saved in:
Bibliographic Details
Title: Defective Mismatch Repair and Benefit from Bevacizumab for Colon Cancer: Findings from NSABP C-08.
Authors: Pogue-Geile, Kay1, Yothers, Greg1,2,3, Yusuke Taniyama1, Noriko Tanaka1, Gavin, Patrick1, Colangelo, Linda1,2,3, Blackmon, Nicole1, Lipchik, Corey1, Seong Rim Kim1, Sharif, Saima1,4, Allegra, Carmen1,5, Petrelli, Nicholas1,6, O'Connell, Michael J.1, Wolmark, Norman1,4, Soonmyung Paik1,7 soon.paik@nsabp.org
Source: JNCI: Journal of the National Cancer Institute. 7/3/2013, Vol. 105 Issue 13, p989-992. 4p. 1 Chart, 1 Graph.
Database: Academic Search Ultimate
Description
ISSN:00278874
DOI:10.1093/jnci/djt140